Innovent Biologics Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Innovent Biologics Inc with three other pharmaceutical manufacturers in Asia: Ensol Biosciences Inc of South Korea (2018 sales of 399.89 million Korean Won [US$336,310.15 ] of which 100% was Pharmaceutical Development and Sales), Syncore Biotechnology Co Ltd of Taiwan (7.71 million Taiwanese Dollars [US$253,296.22 ] ), and Body Organ Biomedical Corp which is also based in Taiwan (24.29 million Taiwanese Dollars [US$798,280.82 ] ).

Sales Analysis.